Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-3,000
Closed -$806K – 86
2023
Q3
$806K Buy
+3,000
New +$749K 0.44% 49

Other funds holding AMGN

DCF Advisers's AMGN Position: Q3 2026 in Review

DCF Advisers reduced its Amgen (AMGN) stake by 38% in Q3 2026, selling an estimated $797K and leaving 3,250 shares worth $1.37M. The position accounts for 0.31% of the portfolio, ranked #61.

DCF Advisers first reported a position in AMGN in Q4 2019 and has held it in 24 quarters since. The position peaked at $4.42M in Q4 2025. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • DCF Advisers held 3,250 shares of Amgen worth $1.37M as of Q3 2026.
  • DCF Advisers sold 2,000 Amgen shares in Q3 2026, an estimated $797K.
  • Amgen made up 0.31% of DCF Advisers's portfolio in Q3 2026, its #61 holding.
  • DCF Advisers first reported a position in Amgen in Q4 2019 and has held it in 24 quarters since.
  • DCF Advisers's Amgen position peaked at $4.42M in Q4 2025.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on DCF Advisers's 13F filing for Q3 2026, filed 4 Nov 2026.